{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:06:32Z","timestamp":1790661992084,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.seizure.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T12:05:25Z","timestamp":1626091525000},"page":"346-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"91","author":[{"given":"Lu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvhua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.07.005_bib0001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-63432-0.00013-X","article-title":"Autoimmune epilepsy","volume":"133","author":"Britton","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"Ong","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0003","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0821-y","article-title":"Treating immune-related epilepsy","volume":"18","author":"Bhatia","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.seizure.2021.07.005_bib0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni0602-500","article-title":"Autoimmune epilepsy","volume":"3","author":"Levite Immunology","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0006","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.seizure.2021.07.005_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/0004-282x20170176","article-title":"Autoimmune encephalitis: a review of diagnosis and treatment","volume":"76","author":"Dutra","year":"2018","journal-title":"Arq de Neuro\u00a0Psiquiatr"},{"key":"10.1016\/j.seizure.2021.07.005_bib0009","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2018.08.009","article-title":"An evolving redefinition of autoimmune encephalitis","volume":"18","author":"Esposito","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.seizure.2021.07.005_bib0011","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","article-title":"Autoimmune encephalitis as differential diagnosis of infectious encephalitis","volume":"27","author":"Armangue","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0012","unstructured":"L. MAGY, Neurologique VALLAT J-MJR. L'enc\u00e9phalopathie de Hashimoto : m\u00e9decine interne et maladies neurologiques\u00a0=\u00a0hashimoto's encephalitis : internal medicine and neurological diseases. 2002."},{"key":"10.1016\/j.seizure.2021.07.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2019","journal-title":"Neurol Neuroimmunol NeuroInflamm"},{"key":"10.1016\/j.seizure.2021.07.005_bib0014","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/epi.16515","article-title":"Seizures in autoimmune encephalitis: kindling the fire","volume":"61","author":"Wesselingh","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-016-0370-7","article-title":"Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival","volume":"27","author":"Harutyunyan","year":"2017","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.seizure.2021.07.005_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14728222.2021.1856370","article-title":"Autoimmune encephalitis: novel therapeutic targets at the preclinical level","volume":"25","author":"Sell","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.seizure.2021.07.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"De Bruijn","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009945.pub2","article-title":"Immunomodulatory interventions for focal epilepsy syndromes","author":"Walker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2021.07.005_bib0019","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2021.07.005_bib0020","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Julian","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2021.07.005_bib0021","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/epi.13929","article-title":"Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study","volume":"58","author":"Liu","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.seizure.2021.07.005_bib0023","article-title":"Influencing electroclinical features and prognostic factors in patients with anti-NMDAR encephalitis: a cohort follow-up study in Chinese patients","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.seizure.2021.07.005_bib0024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jocn.2019.07.049","article-title":"Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in east China","volume":"68","author":"Yao","year":"2019","journal-title":"J. Clin. Neurosci"},{"key":"10.1016\/j.seizure.2021.07.005_bib0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12028-018-0536-6","article-title":"Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients","volume":"29","author":"Zhang","year":"2018","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.seizure.2021.07.005_bib0026","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51137","article-title":"Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis","volume":"7","author":"Shen","year":"2020","journal-title":"Ann. Clin. Transl Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejpn.2019.03.007","article-title":"Pediatric autoimmune encephalitis in Denmark during 2011\u201317: a nationwide multicenter population-based cohort study","volume":"23","author":"Boesen","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00906","article-title":"Pediatric autoimmune encephalitis: case series from two Chinese tertiary pediatric neurology centers","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000396","article-title":"Cryptogenic NORSE Its distinctive clinical features and response to immunotherapy","volume":"4","author":"Iizuka","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.seizure.2021.07.005_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2019.11.011","article-title":"Seizure Characteristics, outcome, and risk of epilepsy in pediatric anti-N-methyl-D-aspartate receptor encephalitis","volume":"105","author":"Qu","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00539","article-title":"Clinical characteristics and short-term prognosis of autoimmune encephalitis: a single-center cohort study in Changsha, China","volume":"10","author":"Deng","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01136","article-title":"Characteristics of seizure and antiepileptic drug utilization in outpatients with autoimmune encephalitis","volume":"9","author":"Huang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0033","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/epi4.12226","article-title":"Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1","volume":"3","author":"Feyissa","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2021.07.005_bib0034","article-title":"Continuous EEG findings in autoimmune encephalitis","author":"Moise","year":"2019","journal-title":"J Clin Neurophysiol Off Publ Am Electroencephalogr Soc"},{"key":"10.1016\/j.seizure.2021.07.005_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(01)00589-5","article-title":"Seizures in Japanese encephalitis","volume":"190","author":"Misra","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2021.07.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-020-04451-0","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical symptoms","author":"Wu","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2021.07.005_bib0037","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2017.09.005","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in children of central south China: clinical features, treatment, influencing factors, and outcomes","volume":"312","author":"Wang","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0038","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01286","article-title":"Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejpn.2017.12.014","article-title":"Initial clinical presentation of young children with N-methyl-D-aspartate receptor encephalitis","volume":"22","author":"Favier","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0041","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.seizure.2020.07.019","article-title":"Seizures and epilepsy of autoimmune origin: a long-term prospective study","volume":"81","author":"Falip","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.005_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00025","article-title":"The different clinical features between autoimmune and infectious status epilepticus","volume":"10","author":"Lin","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0043","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/aian.AIAN_385_16","article-title":"Study of refractory status epilepticus from a tertiary care center","volume":"20","author":"Kohli","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0044","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.12.004","article-title":"Clinical characterization of unknown\/cryptogenic status epilepticus suspected as encephalitis: a multicenter cohort study","volume":"315","author":"Shin","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0046","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010318","article-title":"Neuronal antibody prevalence in children with seizures under 3 years: A prospective national cohort","volume":"95","author":"Symonds","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.005_bib0047","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.seizure.2013.06.004","article-title":"VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"22","author":"Lilleker","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.005_bib0048","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.005_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2018.09.009","article-title":"The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients","volume":"63","author":"Elisak","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.005_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.seizure.2021.07.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/epi.14534","article-title":"Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies","volume":"59","author":"N\u00f3brega-Jr","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0052","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpn.2016.03.005","article-title":"Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis","volume":"20","author":"Borusiak","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0053","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"Critical Care EEGMRC. New-onset refractory status epilepticus","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.005_bib0054","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.seizure.2020.07.021","article-title":"Application of the APE2-CHN and RITE2-CHN scores for autoimmune seizures and epilepsy in Chinese patients: A retrospective study","volume":"81","author":"Liu","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.005_bib0055","first-page":"13","article-title":"Epilepsy and autoimmunity in pediatric patients","volume":"46","author":"Bektas","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.seizure.2021.07.005_bib0056","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/acn3.520","article-title":"Seizure semiology: an important clinical clue to the diagnosis of autoimmune epilepsy","volume":"5","author":"Lv","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0057","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0058","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eplepsyres.2017.06.008","article-title":"Anti-neuronal autoantibodies in both drug responsive and resistant focal seizures with unknown cause","volume":"135","author":"Gozubatik-Celik","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.07.005_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-323841","article-title":"Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study","author":"Bozzetti","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.07.005_bib0060","first-page":"252","article-title":"Neuronal antibodies in paediatric epilepsy: clinical features and long-term outcomes","volume":"56","author":"Wright","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102339","article-title":"The immunobiology of autoimmune encephalitides","volume":"104","author":"Alexopoulos","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.seizure.2021.07.005_bib0062","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neucli.2015.12.009","article-title":"Anti-NMDA-R encephalitis: should we consider extreme delta brush as electrical status epilepticus?","volume":"46","author":"Chanson","year":"2016","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.seizure.2021.07.005_bib0063","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.005_bib0064","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/acn3.50919","article-title":"Hippocampal epileptogenesis in autoimmune encephalitis","volume":"6","author":"Romoli","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2021.07.005_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3345\/kjp.2019.00598","article-title":"Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum","volume":"63","author":"Seo","year":"2020","journal-title":"Clin Exp Pediatr"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:02:34Z","timestamp":1761012154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121002375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":65,"alternative-id":["S1059131121002375"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}